HDAC9 and cancer: Among histone deacetylase inhibitors, the discovery that valproic acid, which belongs to the short-chain fatty acids category and which showed to be an effective HDAC inhibitor [102,103], encouraged investigation of this agent as a potential cancer therapy agent.